Inovalon Results Presentation Deck

Continuous Enhancement & Platform Innovation I inovalon An example of platform capabilities which Inovalon has advanced in their sophistication repeatedly over the years, QSI-XLTM, Inovalon's clinical quality outcomes analytics platform, was further enhanced during the second quarter of 2016. A fully cloud-accessible version, known as the platform's "Client Cloud Access" (or "CCA") version was launched. Able to uniquely handle analyses of the nation's largest healthcare systems' data at very high speeds, interest is very strong for this highly differentiated platform, with multi-year contracts being signed already within the quarter. The strong interest in the platform is spurring additional investments in the Company's capacity to support additional clients. Revenue from these contract signings does not start to come online until late in 2016. The cost of necessary capacity purchasing and provisioning, however, is borne in advance. Early 2000s HEDIS Advantage CARA QSIⓇ Star Advantage Prospective Advantage QSHR QSCL 8 INDICES Data Diagnostics™ QSI-XL™ Quality Spectrum T Policy 360° Slide Graphic for illustrative purposes only. Not all platform capabilities are shown. Underlying technologies (IPORT, PASS, PCIS™, etc.) not displayed. INOV 02 2016 Eamings Presentation Supplement (8.3.16) v1.0.0 EHR Interoperability QSI-XL™ CCA INDICES CCA Star Advantage CCA PAC Platform Current Life Sciences Stack CARA CCA Prospective Advantage CCA © 2016 by Inovalon. All rights reserved.

View entire presentation